Pharming Group N.V.
PHGUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 21.1% | 19.3% | 8.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 80.7% | 89.7% | 90.9% | 89.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 4.6% | 4% | 16.3% | 25.7% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -3.8% | -4.4% | 6.7% | 8.4% |
| EPS Diluted | -0.017 | -0.015 | 0.019 | 0.023 |
| % Growth | -12.7% | -178.9% | -17.4% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |